Ahead of its IPO, the company raised ₹120 crore from two anchor investors on March 13. The company has allotted 3.75 million shares to anchor investors at the upper end at the price of ₹304 to ₹320 per share. Craft Emerging Market Fund PCC and Shine Star Build Cap participated in the anchor round, according to a circular uploaded on BSE’s website.
GSP Crop Science IPO GMP
On Monday, the unlisted shares of GSP Crop Science were trading flat at ₹320, the upper band price, according to the sources tracking unofficial markets.
GSP Crop Science IPO review
According to SBI Securities, the second half of the fiscal year is seasonally weak for crop protection chemical manufacturers, and the current rise in raw material and freight costs due to the Middle East war is likely to impact performance in Q4FY26. Additionally, the 2026 monsoon is likely to be weaker than last year due to the possible development of El Niño conditions, which could impact the acreage and the resultant demand for insecticides, herbicides, and fungicides.
READ | Innovision IPO extended to Mar 17: Check price band, subscription, GMP
Here are the key details of the GSP Crop Science IPO:
GSP Crop Science IPO key dates
The subscription window for the issue will close on Wednesday, March 18, 2026. The share allotment process is expected to be concluded by Friday, March 20. The company is expected to list its shares on the exchanges, NSE and BSE, on Tuesday, March 24.
GSP Crop Science IPO lot size
GSP Crop Science has set the price band for the issue in the range of ₹304 to ₹320 per share. The lot size for an application is 46 shares. Accordingly, a retail investor would require a minimum investment amount of ₹14,720 to bid for at least one lot and in multiples thereof.
GSP Crop Science IPO registrar, lead manager
MUFG Intime India is serving as the registrar for the issue. Equirus Capital and Motilal Oswal Investment Advisors are the book-running lead managers.
GSP Crop Science IPO objective
According to the red herring prospectus (RHP), the company plans to utilise ₹170 crore from the net fresh issue proceeds for repayment or prepayment of certain borrowings availed by the company. The remaining funds will be used for general corporate purposes.